At the hearing, the scientific basis for the risk assessment of glyphosate will be discussed, as well as the alleged influence of industry on this assessment in the US and the EU. The focus is on the so-called 'Monsanto papers': in the context of a US court case brought by plaintiffs claiming that they got cancer due to glyphosate exposure, internal Monsanto emails were released suggesting that the scientific assessment of glyphosate might have been influenced by Monsanto.

The hearing takes place against the background of the ongoing debate over the renewal of glyphosate's approval. The current EU approval expires on 15 December 2017, and the Commission has proposed a renewal for ten years. The hearing should provide Parliament with the necessary information to decide on possible follow-up action.

La Sté Parlement Européen a publié ce contenu, le 05 octobre 2017, et est seule responsable des informations qui y sont renfermées.
Les contenus ont été diffusés par Public non remaniés et non révisés, le05 octobre 2017 15:36:00 UTC.

Document originalhttp://www.europarl.europa.eu/committees/en/envi/home.html

Public permalinkhttp://www.publicnow.com/view/33759F857EF02CF6E34F609E585478F67274B531